In NAFLD animal and FFA-treated cell models, overexpression of lncRNA-H19 (H19) promotes steatosis and increases hepatic lipid accumulation and lipogenesis via the miR-130a/PPARγ axis [140]. The gene discussed is H19; the disease is steatosis.